REGULATION OF RENAL CYCLOOXYGENASE-2

应用程序的目的是确定通过哪些机制 血管紧张素II和内源性糖皮质激素调节血管紧张素转换酶的表达 肾脏中的环氧合酶-2。调查人员提出以下建议 级联发生在延髓粗大的Henle‘s Loop(MTAL)：ALI 诱导肿瘤坏死因子-α，进而诱导环氧合酶-2基因 导致PGE2产生的表达。钠在体内的重吸收 MTAL被前列腺素E_2抑制，从而导致钠尿。的具体目标 项目是：1)确定AII增加COX-2的机制(S 在mTAL和其他肾单位节段的表达，以及2)评估 内源性皮质类固醇对肾脏COX-2的调节及TAL的表型 并鉴定含有环氧合酶-2的细胞。这些具体目标是一种延伸 父母拨款的具体目标。美国调查员将使用 细胞和分子协议，而外国研究人员将在 活体模型、免疫组织化学和原位杂交技术 调查具体目标。

The purpose of the application is to determine the mechanisms by which angiotensin II (AII) and endogenous glucocorticoids regulate expression of cyclooxygenase-2 in the kidney. The investigators propose that the following cascade occurs in medullary thick ascending limb of Henle's loop (mTAL): AII induces tumor necrosis factor-alpha (TNF) which in turn induces COX-2 gene expression which results in the production of PGE2. Sodium reabsorption in the mTAL is inhibited by PGE2 thus resulting in natriuresis. The specific aims of the project are 1) to determine the mechanism(s) by which AII increases COX-2 expression in the mTAL and other nephron segments, and 2) to assess the regulation of renal COX-2 by endogenous corticosteroids and phenotype of TAL and characterize cells that contain COX-2. These specific aims are an extension of the specific aims of the parent grant. The U.S. investigator will use cellular and molecular protocols while the foreign investigator will use in vivo models, immunohistochemical and in situ hybridization techniques to investigate the specific aims.